 Lung Neoplasms
"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
| Descriptor ID |
D008175
|
| MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
| Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 2 | 2 | 4 | | 1982 | 2 | 0 | 2 | | 1983 | 6 | 0 | 6 | | 1984 | 5 | 0 | 5 | | 1985 | 8 | 2 | 10 | | 1986 | 12 | 0 | 12 | | 1987 | 5 | 1 | 6 | | 1988 | 15 | 2 | 17 | | 1989 | 14 | 1 | 15 | | 1990 | 14 | 2 | 16 | | 1991 | 15 | 2 | 17 | | 1992 | 17 | 0 | 17 | | 1993 | 12 | 1 | 13 | | 1994 | 14 | 1 | 15 | | 1995 | 10 | 2 | 12 | | 1996 | 13 | 4 | 17 | | 1997 | 14 | 0 | 14 | | 1998 | 7 | 4 | 11 | | 1999 | 8 | 6 | 14 | | 2000 | 13 | 1 | 14 | | 2001 | 8 | 2 | 10 | | 2002 | 18 | 3 | 21 | | 2003 | 13 | 3 | 16 | | 2004 | 10 | 0 | 10 | | 2005 | 18 | 1 | 19 | | 2006 | 16 | 1 | 17 | | 2007 | 14 | 0 | 14 | | 2008 | 14 | 1 | 15 | | 2009 | 23 | 1 | 24 | | 2010 | 21 | 4 | 25 | | 2011 | 9 | 4 | 13 | | 2012 | 12 | 0 | 12 | | 2013 | 9 | 1 | 10 | | 2014 | 15 | 0 | 15 | | 2015 | 22 | 1 | 23 | | 2016 | 18 | 3 | 21 | | 2017 | 11 | 2 | 13 | | 2018 | 18 | 4 | 22 | | 2019 | 9 | 1 | 10 | | 2020 | 15 | 1 | 16 | | 2021 | 8 | 0 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Gusho CA, Seder CW, Lopez-Hisijos N, Blank AT, Batus M. Pulmonary metastasectomy in bone and soft tissue sarcoma with metastasis to the lung. Interact Cardiovasc Thorac Surg. 2021 11 22; 33(6):879-884.
-
Yang F, Duan M, Zheng F, Yu L, Wang Y, Wang G, Lin J, Han S, Gan D, Meng Z, Zhu S. Fas signaling in adipocytes promotes low-grade inflammation and lung metastasis of colorectal cancer through interaction with Bmx. Cancer Lett. 2021 12 01; 522:93-104.
-
Bestvina CM, Pointer KB, Karrison T, Al-Hallaq H, Hoffman PC, Jelinek MJ, Juloori A, Melotek JM, Murgu S, Partouche J, Vokes EE, Weichselbaum RR, Pitroda SP, Patel JD, Chmura SJ. A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study. J Thorac Oncol. 2022 01; 17(1):130-140.
-
Mathieu LN, Larkins E, Akinboro O, Roy P, Amatya AK, Fiero MH, Mishra-Kalyani PS, Helms WS, Myers CE, Skinner AM, Aungst S, Jin R, Zhao H, Xia H, Zirkelbach JF, Bi Y, Li Y, Liu J, Grimstein M, Zhang X, Woods S, Reece K, Abukhdeir AM, Ghosh S, Philip R, Tang S, Goldberg KB, Pazdur R, Beaver JA, Singh H. FDA Approval Summary: Capmatinib and Tepotinib for the Treatment of Metastatic NSCLC Harboring MET Exon 14 Skipping Mutations or Alterations. Clin Cancer Res. 2022 01 15; 28(2):249-254.
-
Warren GW, Lim VS, Chowdhary M, Marwaha G, Abd Elbadee OM, Kirakli EK, Billiet C, Marin AG, Ramos M, Suppli MH, McGinnis GJ, Adjei AA. New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019. J Thorac Oncol. 2021 11; 16(11):1946-1951.
-
Rizzo A, Mulshine JL. Thoracic CT screening: using routinely detectable COPD information. Clin Imaging. 2021 Oct; 78:310-312.
-
Arndt AT, Brunelli A, Cicconi S, Falcoz PE, Salati M, Kozower B, Liptay MJ, Rocco G, Karush JM, Geissen N, Basu S, Seder CW. Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS Registry. Lung. 2021 06; 199(3):311-318.
-
Tarhoni I, Wakefield CJ, Kollipara R, Fidler MJ, Batus M, Bonomi P, Borgia JA. Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint inhibition. J Immunol Methods. 2021 03; 490:112956.
-
Jelinek MJ, Aggarwal C. Adjuvant Osimertinib: A New Standard of Care. Oncologist. 2021 04; 26(4):263-265.
-
Bryan DS, Ferguson MK, Antonoff MB, Backhus LM, Birdas TJ, Blackmon SH, Boffa DJ, Chang AC, Chmielewski GW, Cooke DT, Donington JS, Gaissert HA, Hagen JA, Hofstetter WL, Kent MS, Kim KW, Krantz SB, Lin J, Martin LW, Meyerson SL, Mitchell JD, Molena D, Odell DD, Onaitis MW, Puri V, Putnam JB, Seder CW, Shrager JB, Soukiasian HJ, Stiles BM, Tong BC, Veeramachaneni NK. Consensus for Thoracoscopic Left Upper Lobectomy-Essential Components and Targets for Simulation. Ann Thorac Surg. 2021 08; 112(2):436-442.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|